Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (161-170 of 587) with videos related to

Pageof 59
Sort By:
Acta Psychiatrica Scandinavica|July 6, 2017
4-HYDROXY-3-METHOXYPHENYLGLYCOL AS AN INDEX OF BRAIN NORADRENALINE TURNOVER IN ENDOGENOUS DEPRESSIONP Riederer, W Birkmayer, D Seemann, et al.
Journal of Neural Transmission. Supplementum|November 7, 2007
Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysisF Tribl, T Arzberger, P Riederer, et al.
Journal of Neural Transmission|January 1, 1973
L-dopa level in plasma, primary condition for the kinetic effectW Birkmayer, W Danielcyk, E Neumayer, et al.
Journal of Neural Transmission|January 1, 1974
Nucleus ruber and L-dopa psychosis: biochemical post-mortem findingsW Birkmayer, W Danielczyk, E Neumayer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Characterization of [3H]pentazocine binding sites in post-mortem human frontal cortexJ Kornhuber, K Schoppmeyer, C Bendig, et al.
Journal of Neural Transmission. Supplementum|January 1, 1987
Cellular action of MAO inhibitorsC Konradi, P Riederer, K Jellinger, et al.
British Journal of Clinical Pharmacology|May 1, 1980
Effects of tranylcypromine stereoisomers on monamine oxidation in manG P Reynolds, W D Rausch, P Riederer
Lancet (London, England)|October 19, 1991
Pharmacotoxic psychosis after memantine in Parkinson's diseaseP Riederer, K W Lange, J Kornhuber, et al.
Wiener Klinische Wochenschrift|August 28, 1987
[Metabolic changes in ischemic brain infarct]K Schnecker, W D Rausch, J Bruck, et al.
Neuroscience Letters|August 17, 1992
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's diseaseE Sofic, K W Lange, K Jellinger, et al.
Pageof 59

Showing results (161-170 of 587) with videos related to

Sort By:
Pageof 59
Acta Psychiatrica Scandinavica|July 6, 2017
4-HYDROXY-3-METHOXYPHENYLGLYCOL AS AN INDEX OF BRAIN NORADRENALINE TURNOVER IN ENDOGENOUS DEPRESSIONP Riederer, W Birkmayer, D Seemann, et al.
Journal of Neural Transmission. Supplementum|November 7, 2007
Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysisF Tribl, T Arzberger, P Riederer, et al.
Journal of Neural Transmission|January 1, 1973
L-dopa level in plasma, primary condition for the kinetic effectW Birkmayer, W Danielcyk, E Neumayer, et al.
Journal of Neural Transmission|January 1, 1974
Nucleus ruber and L-dopa psychosis: biochemical post-mortem findingsW Birkmayer, W Danielczyk, E Neumayer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Characterization of [3H]pentazocine binding sites in post-mortem human frontal cortexJ Kornhuber, K Schoppmeyer, C Bendig, et al.
Journal of Neural Transmission. Supplementum|January 1, 1987
Cellular action of MAO inhibitorsC Konradi, P Riederer, K Jellinger, et al.
British Journal of Clinical Pharmacology|May 1, 1980
Effects of tranylcypromine stereoisomers on monamine oxidation in manG P Reynolds, W D Rausch, P Riederer
Lancet (London, England)|October 19, 1991
Pharmacotoxic psychosis after memantine in Parkinson's diseaseP Riederer, K W Lange, J Kornhuber, et al.
Wiener Klinische Wochenschrift|August 28, 1987
[Metabolic changes in ischemic brain infarct]K Schnecker, W D Rausch, J Bruck, et al.
Neuroscience Letters|August 17, 1992
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's diseaseE Sofic, K W Lange, K Jellinger, et al.
Pageof 59